Page last updated: 2024-08-22

angiotensin ii and Liver Steatosis

angiotensin ii has been researched along with Liver Steatosis in 22 studies

Research

Studies (22)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (18.18)	18.7374
1990's	0 (0.00)	18.2507
2000's	8 (36.36)	29.6817
2010's	10 (45.45)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bento-Bernardes, T; Conte-Junior, CA; Fernandes, T; Fernandes-Santos, C; Frantz, EDC; Gaique, TG; Giori, IG; Lima, JBS; Medeiros, RF; Nobrega, ACL; Oliveira, EM; Oliveira, KJ; Vieira, CP	1
Liu, ML; Qiu, Q; Wang, L; Wu, XL; Xu, YZ; Zhang, F; Zhang, GR; Zhang, X	1
Baba, A; Kochi, T; Kubota, M; Moriwaki, H; Ohno, T; Shimizu, M; Shirakami, Y; Tanaka, T; Terakura, D; Tsurumi, H	1
Chan, CC; Hsieh, YC; Huang, YH; Lee, KC; Lin, HC; Yang, YY	1
Balakrishnan, A; Cassis, LA; Chen, X; Crooke, RM; Daugherty, A; Feldman, DL; Graham, MJ; Howatt, DA; Lu, H; Moorleghen, JJ; Mullick, AE; Vander Kooi, CW; Wu, C; Zhao, M	1
Alfany-Fernandez, I; Bintanel-Morcillo, M; Brosnihan, KB; Casillas-Ramirez, A; Ferrario, CM; Peralta, C; Rimola, A; Rodés, J; Roselló-Catafau, J; Serafin, A	1
Clark, SE; Ferrario, CM; Ibdah, JA; Li, W; Sowers, JR; Thyfault, JP; Uptergrove, GM; Wei, Y; Whaley-Connell, AT	1
Bataller, R; Colmenero, J; De Minicis, S; Gwak, GY; Kluwe, J; Mencin, A; Osterreicher, CH; Pradere, JP; Schwabe, RF	1
Jin, D; Miyazaki, M; Takai, S	1
Aihara, Y; Fukui, H; Ikenaka, Y; Kaji, K; Kawaratani, H; Kitade, M; Namisaki, T; Noguchi, R; Shirai, Y; Tsujimoto, T; Yanase, K; Yoshii, J; Yoshiji, H	1
Fletcher, JA; Matthew Morris, E; Rector, RS; Thyfault, JP	1
Aihara, Y; Douhara, A; Fukui, H; Kaji, K; Kawaratani, H; Moriya, K; Namisaki, T; Noguchi, R; Shirai, Y; Yoshiji, H	1
Argentino, DP; Dominici, FP; Muñoz, MC; Toblli, JE; Turyn, D	1
Chiarelli, F; Di Marzio, D; Giannini, C; Mohn, A; Mokini, ZH	1
Hibi, T; Horikawa, H; Ishii, H; Kitamura, K; Kumagai, N; Kurita, S; Nakamoto, N; Saito, H; Tada, S; Toda, K; Tsunematsu, S	1
Cao, G; Mastai, R; Mella, J; Muñoz, MC; Pereyra, L; Toblli, JE	1
Amine-Zaouali, M; Arroyo, V; Bintanel-Morcillo, M; Casillas-Ramirez, A; Massip-Salcedo, M; Padrissa-Altés, S; Peralta, C; Ramalho, F; Rimola, A; Rodés, J; Roselló-Catafau, J; Serafín, A	1
Clark, SE; Ferrario, CM; Ibdah, JA; Morris, EM; Sowers, JR; Thyfault, JP; Uptergrove, GM; Wei, Y; Whaley-Connell, AT	1
Frank, MJ; Levinson, GE; Moschos, CB; Oldewurtel, HA; Regan, TJ; Weisse, AB	1
Bumpus, FM; Carretero, OA; Smeby, RR	1
Bourel, M; Chauvel, A; Lenoir, P; Pawlotsky, Y; Pirot, D; Simon, M	1
Loyke, HF	1

Reviews

3 review(s) available for angiotensin ii and Liver Steatosis

Article	Year
Chymase as an important target for preventing complications of metabolic syndrome. Current medicinal chemistry, 2010, Volume: 17, Issue:28 Topics: Angiotensin II; Animals; Atherosclerosis; Chymases; Diabetes Complications; Diabetic Retinopathy; Fatty Liver; Humans; Hypertension; Matrix Metalloproteinase 9; Metabolic Syndrome; Mice; Transforming Growth Factor beta	2010
The role of angiotensin II in nonalcoholic steatohepatitis. Molecular and cellular endocrinology, 2013, Sep-25, Volume: 378, Issue:1-2 Topics: Angiotensin II; Animals; Chronic Disease; Fatty Liver; Humans; Insulin Resistance; Liver Cirrhosis; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Renin-Angiotensin System; Signal Transduction	2013
Macroangiopathy in adults and children with diabetes: from molecular mechanisms to vascular damage (part 1). Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2006, Volume: 38, Issue:11 Topics: Adult; Angiotensin I; Angiotensin II; Atherosclerosis; Child; Cholesterol, LDL; Diabetic Angiopathies; Fatty Liver; Humans; Inflammation; Macrophages; Thrombosis	2006

Other Studies

19 other study(ies) available for angiotensin ii and Liver Steatosis

Article	Year
Exercise training modulates the hepatic renin-angiotensin system in fructose-fed rats. Experimental physiology, 2017, 09-01, Volume: 102, Issue:9 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Fatty Liver; Fructose; Gluconeogenesis; Interleukin-6; Lipid Metabolism; Liver; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Physical Conditioning, Animal; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tumor Necrosis Factor-alpha	2017
An increased circulating angiotensin II concentration is associated with hypoadiponectinemia and postprandial hyperglycemia in men with nonalcoholic fatty liver disease. Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:8 Topics: Adiponectin; Adult; Angiotensin II; Biomarkers; Blood Circulation; Fatty Liver; Humans; Hyperglycemia; Male; Metabolism, Inborn Errors; Middle Aged; Non-alcoholic Fatty Liver Disease	2013
Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions. Cancer letters, 2014, Jan-01, Volume: 342, Issue:1 Topics: Angiotensin II; Animals; Anticarcinogenic Agents; Catechin; Fatty Liver; Gene Expression; Hypertension; Interleukin-6; Lipid Peroxidation; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Peptidyl-Dipeptidase A; Precancerous Conditions; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Tumor Necrosis Factor-alpha	2014
Aliskiren attenuates steatohepatitis and increases turnover of hepatic fat in mice fed with a methionine and choline deficient diet. PloS one, 2013, Volume: 8, Issue:10 Topics: Amides; Angiotensin II; Animals; Blotting, Western; Choline; Diet; Fatty Liver; Fumarates; Immunoenzyme Techniques; Inflammation; Insulin; Liver; Male; Methionine; Mice; Mice, Inbred C57BL; Oxidative Stress; Real-Time Polymerase Chain Reaction; Renin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiobarbituric Acid Reactive Substances; Triglycerides	2013
Angiotensinogen Exerts Effects Independent of Angiotensin II. Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:2 Topics: Amides; Amino Acid Sequence; Angiotensin II; Angiotensinogen; Animals; Atherosclerosis; Blood Pressure; Conserved Sequence; Dependovirus; Diet, High-Fat; Disease Models, Animal; Fatty Liver; Fumarates; Genetic Vectors; Genotype; Hepatocytes; Hypertension; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Models, Molecular; Oligonucleotides, Antisense; Phenotype; Protein Binding; Protein Interaction Domains and Motifs; Receptors, LDL; Renin; Signal Transduction; Time Factors; Transduction, Genetic; Weight Gain	2016
Therapeutic targets in liver transplantation: angiotensin II in nonsteatotic grafts and angiotensin-(1-7) in steatotic grafts. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2009, Volume: 9, Issue:3 Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Apoptosis; Fatty Liver; Graft Survival; Health; Liver Transplantation; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Peptide Fragments; Rats; Receptors, Angiotensin	2009
Oxidative stress-mediated mitochondrial dysfunction contributes to angiotensin II-induced nonalcoholic fatty liver disease in transgenic Ren2 rats. The American journal of pathology, 2009, Volume: 174, Issue:4 Topics: Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Blotting, Western; Cyclic N-Oxides; DNA, Mitochondrial; Fatty Acids; Fatty Liver; Gene Expression; Immunohistochemistry; Male; Microscopy, Electron, Transmission; Mitochondria; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Reverse Transcriptase Polymerase Chain Reaction; Spin Labels; Tetrazoles; Valine; Valsartan	2009
Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition. Gastroenterology, 2010, Volume: 138, Issue:1 Topics: Angiotensin II; Animals; Anthracenes; Carrier Proteins; Cell Division; Cells, Cultured; Disease Models, Animal; Fatty Liver; Fibroblasts; Hepatic Stellate Cells; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Mutant Strains; Mitogen-Activated Protein Kinase 9; Phosphorylation; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Transforming Growth Factor beta	2010
Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats. American journal of physiology. Gastrointestinal and liver physiology, 2011, Volume: 300, Issue:6 Topics: Administration, Oral; Angiogenesis Inhibitors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzoates; Carcinoma, Hepatocellular; Cell Proliferation; Cells, Cultured; Choline Deficiency; Deferasirox; Disease Progression; Drug Therapy, Combination; Fatty Liver; Hepatic Stellate Cells; Iron Chelating Agents; Liver Cirrhosis, Experimental; Liver Neoplasms, Experimental; Losartan; Male; Neovascularization, Pathologic; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats; Rats, Inbred F344; Time Factors; Transforming Growth Factor beta1; Triazoles	2011
Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis. Journal of gastroenterology and hepatology, 2013, Volume: 28, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Communication; Disease Models, Animal; Disease Progression; DNA Primers; Dose-Response Relationship, Drug; Fatty Liver; Gene Expression; Hepatic Stellate Cells; Liver Cirrhosis; Losartan; Male; NF-kappa B; Non-alcoholic Fatty Liver Disease; Rats; Rats, Inbred F344; Real-Time Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Time Factors; Toll-Like Receptor 4; Transforming Growth Factor beta	2013
Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats. Journal of hypertension, 2006, Volume: 24, Issue:8 Topics: Adaptor Proteins, Signal Transducing; Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biomarkers; Biphenyl Compounds; Blood Pressure; Disease Models, Animal; Enzyme Activation; Fatty Liver; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Irbesartan; Male; Mitogen-Activated Protein Kinase 3; Obesity; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Zucker; Receptor, Insulin; Shc Signaling Adaptor Proteins; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1; Tetrazoles	2006
Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis. Journal of gastroenterology and hepatology, 2007, Volume: 22, Issue:11 Topics: Alanine Transaminase; Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aspartate Aminotransferases; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Choline Deficiency; Disease Models, Animal; DNA Damage; Fatty Liver; Liver; Liver Cirrhosis; Male; Organ Size; Oxidative Stress; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Wistar; Reactive Oxygen Species; rho GTP-Binding Proteins; rho-Associated Kinases; RNA, Messenger; Signal Transduction; Tetrazoles; Time Factors; Tumor Necrosis Factor-alpha	2007
ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats. Obesity (Silver Spring, Md.), 2008, Volume: 16, Issue:4 Topics: Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Disease Models, Animal; Fatty Liver; Interleukin-6; Irbesartan; Liver; Liver Cirrhosis; Male; Metabolic Syndrome; Obesity; Perindopril; Rats; Rats, Zucker; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha	2008
Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury. Critical care medicine, 2008, Volume: 36, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Fatty Liver; Interleukin-10; Rats; Rats, Zucker; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction	2008
Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats. Journal of hepatology, 2008, Volume: 49, Issue:3 Topics: Angiotensin II; Animals; Animals, Genetically Modified; Antihypertensive Agents; Antioxidants; Apoptosis; Blood Pressure; Cyclic N-Oxides; Disease Models, Animal; Fatty Liver; Lipid Peroxidation; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Renin; Renin-Angiotensin System; Spin Labels; Tetrazoles; Valine; Valsartan	2008
Ventricular function in noncardiacs with alcoholic fatty liver: role of ethanol in the production of cardiomyopathy. The Journal of clinical investigation, 1969, Volume: 48, Issue:2 Topics: Adult; Alcoholism; Angiotensin II; Blood Circulation; Blood Pressure; Carbohydrate Metabolism; Ethanol; Fatty Acids, Nonesterified; Fatty Liver; Heart; Heart Diseases; Heart Rate; Heart Ventricles; Humans; Male; Phosphates; Potassium; Transaminases; Triglycerides; Urine	1969
Pressor response to angiotensins I and II and renin in rats treated with carbon tetrachloride. Nature, 1969, Mar-15, Volume: 221, Issue:5185 Topics: Angiotensin II; Animals; Blood Pressure; Carbon Tetrachloride Poisoning; Dipeptidases; Fatty Liver; Female; Hypertension; Liver; Rats; Renin	1969
[Contribution to the study of the interference of the renin-angiotensin-aldosterone system during the development of chronic alcoholic hepatopathy]. Revue internationale d'hepatologie, 1968, Volume: 18, Issue:7 Topics: Adult; Alcoholism; Angiotensin II; Blood Volume; Fatty Liver; Female; Humans; Hyperaldosteronism; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Natriuresis; Potassium; Renin	1968
Converting enzyme in rat serum. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1970, Volume: 134, Issue:1 Topics: Angiotensin II; Animals; Blood Pressure; Carbon Tetrachloride Poisoning; Endopeptidases; Fatty Liver; Hypertension, Renal; Liver; Pyelonephritis; Rats	1970